Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
PubMed Central, Hogan, A
Cost-effectiveness of SGLT2is Under the assumptions of our model, use of SGLT2is was cost-effective: SGLT2i use met the AU$28,000 per QALY willingness-to-pay threshold in most one-way sensitivity and scenario analyses in both populations, and also did so in most probabilistic sensitivity analyses, especially in the secondary prevention population
Monteiro P, Bergenstal RM, Toural E, Inzucchi SE, Zinman B, Hantel S, et al
To be conservative, we used the maximum possible disutility for each health state
Each targets a different concern: B12 for energy and nerve health, niacinamide for skin and metabolic support, glycine for GI tolerability, and levocarnitine for fat metabolism optimization
